AMGN Amgen Inc. Stock Quote

AMGN [NASD]

Healthcare | Drug Manufacturers - General | USA

Index	DJIA S&P500	P/E	24.02	EPS (ttm)	10.16	Insider Own	0.20%	Shs Outstand	563.27M	Perf Week	1.38%
Market Cap	131.03B	Forward P/E	12.80	EPS next Y	19.05	Insider Trans	-1.24%	Shs Float	562.18M	Perf Month	-3.71%
Income	5.72B	PEG	3.40	EPS next Q	4.40	Inst Own	81.60%	Short Float	3.54%	Perf Quarter	9.57%
Sales	26.32B	P/S	4.98	EPS this Y	-16.50%	Inst Trans	0.30%	Short Ratio	6.26	Perf Half Y	18.78%
Book/sh	1.67	P/B	146.08	EPS next Y	9.15%	ROA	9.30%	Target Price	249.25	Perf Year	-1.88%
Cash/sh	12.18	P/C	20.02	EPS next 5Y	7.07%	ROE	95.10%	52W Range	198.64 - 258.45	Perf YTD	8.44%
Dividend	7.76	P/FCF	30.19	EPS past 5Y	0.10%	ROI	17.10%	52W High	-6.03%	Beta	0.55
Dividend %	3.18%	Quick Ratio	1.10	Sales past 5Y	2.50%	Gross Margin	75.20%	52W Low	22.27%	ATR	5.55
Employees	24200	Current Ratio	1.40	Sales Q/Q	5.70%	Oper. Margin	30.40%	RSI (14)	50.93	Volatility	2.05% 2.32%
Optionable	Yes	Debt/Eq	40.23	EPS Q/Q	-5.40%	Profit Margin	21.70%	Rel Volume	0.69	Prev Close	243.96
Shortable	Yes	LT Debt/Eq	39.31	Earnings	Apr 27 AMC	Payout	70.80%	Avg Volume	3.18M	Price	242.87
Recom	2.50	SMA20	0.36%	SMA50	0.39%	SMA200	8.07%	Volume	653,841	Change	-0.45%

Feb-09-22

Reiterated

Wells Fargo

Equal Weight

$210 → $250

Feb-09-22

Reiterated

Oppenheimer

Outperform

$272 → $285

Feb-09-22

Reiterated

Morgan Stanley

Equal-Weight

$235 → $238

Feb-09-22

Reiterated

Jefferies

Buy

$266 → $280

Feb-09-22

Reiterated

Barclays

Equal Weight

$228 → $233

Jan-05-22

Downgrade

BofA Securities

Buy → Neutral

$285 → $255

Dec-09-21

Resumed

Wells Fargo

Equal Weight

$210

Dec-06-21

Initiated

Goldman

Buy

$258

Nov-19-21

Initiated

BMO Capital Markets

Market Perform

$228

Sep-23-21

Downgrade

Daiwa Securities

Outperform → Neutral

$220

Sep-07-21

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$280 → $251

Dec-29-20

Initiated

Daiwa Securities

Buy

$300

Oct-28-20

Initiated

UBS

Neutral

$232

Oct-26-20

Upgrade

Raymond James

Mkt Perform → Outperform

$255

Oct-12-20

Upgrade

Truist

Hold → Buy

Oct-09-20

Downgrade

Truist

Buy → Hold

$251

Oct-09-20

Downgrade

Bernstein

Outperform → Mkt Perform

Oct-08-20

Downgrade

Raymond James

Outperform → Mkt Perform

Apr-15-20

Resumed

Guggenheim

Neutral

Mar-31-20

Initiated

Wolfe Research

Peer Perform

May-17-22 06:15AM	5 Beaten-Down Blue-Chip Stocks to Buy Now InvestorPlace
May-13-22 02:29PM	BridgeBio (BBIO) Up on Deal With BMY for SHP2 Inhibitor Zacks
08:33AM	The Zacks Analyst Blog Highlights Amgen, Altria Group, Uber Technologies, Microchip Technology, and Arista Networks Zacks
May-12-22 12:45PM	Top Research Reports for Amgen, Altria Group & Uber Zacks
08:00AM	AMGEN AND LANCE BASS PARTNER TO ENCOURAGE PEOPLE TO DO A 'DOUBLE TAKE' TO RECOGNIZE THE EARLY SIGNS OF PSORIATIC ARTHRITIS PR Newswire
06:12AM	Three Days Left To Buy Amgen Inc. (NASDAQ:AMGN) Before The Ex-Dividend Date Simply Wall St.
May-10-22 02:05PM	How Are Biotech ETFs Reacting to These Q1 Earnings Releases? Zacks
May-06-22 04:00PM	AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA HEALTHCARE CONFERENCE PR Newswire
12:43PM	Radius (RDUS) Q1 Loss Wider Than Expected, Revenues Decline Zacks
07:33AM	7 Defensive Dividend Healthcare Stocks to Buy Now InvestorPlace
May-05-22 11:00PM	Best Places to Work 2022: Our Wellness Winners prioritize employee mental health American City Business Journals
03:33PM	Dow Jones Plummets Over 1,200 Points; These Three Growth Stocks Manage To Break Out Investor's Business Daily
08:20AM	Should Investors Be Worried About Amgen's Q1 Results? Motley Fool
May-04-22 01:39PM	Biotech Stock Roundup: BIIB & GILD's Earnings Update, VRTX Down on Regulatory News Zacks
May-03-22 03:01PM	Apple, Toyota help keep NC best in US for economic development success American City Business Journals
10:42AM	Pfizer (PFE) Q1 Earnings & Sales Miss Estimates, Stock Down Zacks
06:20AM	Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar? Zacks
06:01AM	1 Green Flag and 1 Red Flag for Amgen Motley Fool
May-02-22 09:00AM	AMGEN RELEASES ANNUAL ENVIRONMENTAL, SOCIAL & GOVERNANCE REPORT PR Newswire
May-01-22 06:45AM	1 Top Dividend Stock to Buy and Hold Forever Motley Fool
Apr-29-22 11:20AM	AbbVie (ABBV) Q1 Earnings Top, Competition Rises for Imbruvica Zacks
Apr-28-22 04:21PM	Stocks set to erase losses from earlier in the week Yahoo Finance Video
01:44PM	11 Stocks Making Big Moves on Earnings Reports Insider Monkey
01:33PM	Bizarre Potential $7.1 Billion Tax Bill Sinks Amgen Shares Bloomberg
10:44AM	Amgen's (AMGN) Q1 Earnings Top, Stock Down on IRS Tax Dispute Zacks
09:33AM	Dow Jones Rallies As Facebook Soars 18% On Earnings; Apple Earnings Due Investor's Business Daily
06:30AM	Amgen's Q1 Better Than Expected Sales, Profit Overshadowed By Tax Disclosure Benzinga
04:51AM	Amgen Falls After Revealing a $7 Billion IRS Tax Bill Barrons.com
02:07AM	PRESS DIGEST- Wall Street Journal - April 28 Reuters
Apr-27-22 05:28PM	Biotech Behemoth Amgen Tops First-Quarter Views, But 2022 Guidance Lags Investor's Business Daily
05:25PM	Amgen (AMGN) Surpasses Q1 Earnings and Revenue Estimates Zacks
05:03PM	Amgen Q1 revenue beats expectations, profit declines MarketWatch
04:52PM	UPDATE 3-Amgen says IRS seeks billions in back taxes, shares fall 6% Reuters
04:34PM	Amgen says IRS seeks billions in back taxes, shares fall 6% Reuters
04:34PM	Amgen says IRS seeks billions in back taxes, shares fall 4% Reuters
04:26PM	Amgen says IRS seeks another $5.1 billion in back taxes Reuters
04:01PM	AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS PR Newswire
09:00AM	AMGEN ANNOUNCES RESULTS FROM TWO OPEN LABEL EXTENSION STUDIES OF REPATHA® (EVOLOCUMAB) PR Newswire
08:02AM	Molecular Partners shares tumble 37% after Amgen returns rights to tumor treatment candidate MarketWatch
06:01AM	Molecular Partners Regains Rights To Early-Stage Cancer Asset From Amgen Benzinga
Apr-26-22 11:44AM	Drug/Biotech Stocks' Apr 27 Q1 Earnings Roster: GSK, AMGN & More Zacks
11:15AM	Healthcare ETFs in Focus Ahead of Q1 Earnings Zacks
05:50AM	The Zacks Analyst Blog Highlights Amgen, Chevron, Coca-Cola, Visa and Merck Zacks
Apr-25-22 11:49AM	Gilead (GILD) to Report Q1 Earnings: Is a Beat in the Cards? Zacks
08:44AM	Why Amgen (AMGN) Might Surprise This Earnings Season Zacks
06:18AM	5 Blue-Chip Stocks Likely to Gain on Earnings Results This Week Zacks
Apr-22-22 04:00PM	AMGEN ANNOUNCES WEBCAST OF 2022 FIRST QUARTER FINANCIAL RESULTS PR Newswire
09:53AM	Is a Beat Likely for Amgen (AMGN) This Earnings Season? Zacks
07:50AM	The Smartest Dividend Stocks to Buy With $400 Right Now Motley Fool
Apr-21-22 06:00PM	Amgen (AMGN) Gains As Market Dips: What You Should Know Zacks
Apr-20-22 12:10PM	Can Amgen (AMGN) Keep the Earnings Surprise Streak Alive? Zacks
08:23AM	Glaxo's (GSK) NDA for Daprodustat Gets Accepted by the FDA Zacks
Apr-19-22 06:15PM	Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
03:00PM	Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Q1 Release Zacks
10:57AM	Shareholders push for review of lobbying by Gilead, other drugmakers American City Business Journals
09:15AM	Amgen's (AMGN) Stelara Biosimilar Meets Psoriasis Study Goal Zacks
06:30AM	Want to Invest Your Tax Refund? 3 Long-Term Stocks to Consider InvestorPlace
Apr-18-22 04:00PM	AMGEN ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY OF ABP 654, BIOSIMILAR CANDIDATE TO STELARA® (USTEKINUMAB) PR Newswire
12:53PM	Amgen's Dividend Can Weather Any Storm GuruFocus.com
Apr-14-22 10:38AM	10 Dividend Stocks to Buy Now According to Kerr Neilsons Hedge Fund Insider Monkey
05:55AM	The Petri Dish: Flagship appoints new CEO-partners, Ginkgo partners on another spinout American City Business Journals
Apr-13-22 06:00PM	Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know Zacks
Apr-12-22 02:09PM	Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 79% gain Simply Wall St.
10:23AM	BeiGene (BGNE) Brukinsa Superior to Imbruvica in Leukemia Study Zacks
Apr-11-22 06:15PM	Amgen (AMGN) Stock Moves -0.46%: What You Should Know Zacks
12:21PM	Biomea Fusion Shares BMF-219 Preclinical Data At AACR 2022 Meeting Benzinga
Apr-10-22 12:00PM	LUMAKRAS® (SOTORASIB) CODEBREAK 100 STUDY SHOWS TWO-YEAR OVERALL SURVIVAL OF 32.5% IN PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER PR Newswire
Apr-08-22 03:17PM	Esperion's (ESPR) Drug Sales and Cost-Cutting Drive Stock YTD Zacks
Apr-06-22 10:15AM	10 Biotech Penny Stocks with Growth Catalysts Insider Monkey
Apr-05-22 06:00PM	Amgen (AMGN) Stock Moves -0.13%: What You Should Know Zacks
Apr-04-22 06:15PM	Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
Apr-03-22 06:10AM	3 Biotech Stocks to Buy in April Motley Fool
Apr-01-22 10:45AM	2 Top Dividend Stocks for 2022 Motley Fool
Mar-29-22 06:00PM	Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
12:23PM	Amgen Mulls More Green Bonds After Robust Interest in Debut Bloomberg
Mar-28-22 06:15PM	Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
Mar-25-22 09:00AM	AMGEN ANNOUNCES NEW OTEZLA (APREMILAST) DATA AT AAD CONGRESS 2022 PR Newswire
Mar-24-22 08:38AM	Are Options Traders Betting on a Big Move in Amgen (AMGN) Stock? Zacks
06:09AM	The Zacks Analyst Blog Highlights Comcast, Danaher, Amgen, Boeing and Canadian Pacific Railway Zacks
Mar-23-22 05:20PM	Top Stock Reports for Comcast, Danaher & Amgen Zacks
Mar-22-22 06:00PM	Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
Mar-21-22 06:15PM	Amgen (AMGN) Gains As Market Dips: What You Should Know Zacks
09:05AM	Amgen (AMGN) Outperforms Industry This Year So Far: What Next? Zacks
Mar-20-22 08:03AM	3 Dividend Stocks That We'd Buy Without Any Hesitation Motley Fool
Mar-17-22 02:03PM	Fed Trying to Play Catch-Up (Capital Market Research) (Weekly Market Outlook) Moody's
Mar-16-22 11:15AM	1 Great Income Stock to Buy and Hold Forever Motley Fool
09:09AM	Sanofi (SNY), Blackstone Ink Deal for Subcutaneous Sarclisa Zacks
Mar-14-22 06:00PM	Amgen (AMGN) Gains As Market Dips: What You Should Know Zacks
03:02PM	10 ETFs to Buy and Hold for the Next 10 Years Insider Monkey
Mar-11-22 12:06PM	Mirati (MRTX) Focuses on Seeking Nod for KRAS Drug Adagrasib Zacks
11:09AM	AbbVie's (ABBV) Qulipta Meets Chronic Migraine Study Endpoints Zacks
Mar-10-22 04:00PM	Amgen To Present At The 32nd annual Oppenheimer Healthcare Conference PR Newswire
Mar-09-22 11:30AM	Amgen (AMGN) Down 4.1% Since Last Earnings Report: Can It Rebound? Zacks
Mar-08-22 06:00PM	Amgen (AMGN) Dips More Than Broader Markets: What You Should Know Zacks
04:30PM	AMGEN TO PRESENT LONG-TERM OUTCOMES FOR LUMAKRAS® (SOTORASIB) IN KRAS G12C-MUTATED NSCLC AT AACR 2022 PR Newswire
Mar-07-22 09:11PM	Global biotech breaks ground on 355-job Holly Springs facility. Here's when hiring will ramp up. American City Business Journals
04:00PM	GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH CAROLINA PR Newswire
Mar-06-22 10:45AM	3 Top Healthcare Stocks to Buy for March Motley Fool
Mar-02-22 06:00PM	Amgen (AMGN) Gains But Lags Market: What You Should Know Zacks
04:15PM	AMGEN TO PRESENT AT THE 42ND ANNUAL COWEN HEALTHCARE CONFERENCE PR Newswire

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behcet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Graham Jonathan P	EVP, Gen. Counsel & Secy.	May 10	Sale	241.81	13,500	3,264,454	37,333	May 10 07:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience